The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3652 in First-in-Human and Ascending Multiple Oral Dose Studies in Healthy Subjects
posted on 2020-06-11, 08:49authored byMasaomi Takizawa, Dirk Cerneus, Ingrid Michon, Sanne Rijnders, Desiree van der Heide, John Meijer, Matthias Stoelzel, Yuichiro Sato
Article full
text
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).